155 related articles for article (PubMed ID: 35192641)
1. Association of serum fibroblast growth factor 21 with diabetic complications and insulin dose in patients with type 1 diabetes mellitus.
Taniguchi H; Nirengi S; Ishihara K; Sakane N
PLoS One; 2022; 17(2):e0263774. PubMed ID: 35192641
[TBL] [Abstract][Full Text] [Related]
2. FGF21 and glycemic control in patients with T1D.
Rosell Rask S; Krarup Hansen T; Bjerre M
Endocrine; 2019 Sep; 65(3):550-557. PubMed ID: 31372821
[TBL] [Abstract][Full Text] [Related]
3. Distinct changes in serum fibroblast growth factor 21 levels in different subtypes of diabetes.
Xiao Y; Xu A; Law LS; Chen C; Li H; Li X; Yang L; Liu S; Zhou Z; Lam KS
J Clin Endocrinol Metab; 2012 Jan; 97(1):E54-8. PubMed ID: 22013098
[TBL] [Abstract][Full Text] [Related]
4. The U-shaped relationship between fibroblast growth factor 21 and microvascular complication in type 2 diabetes mellitus.
Jung CH; Jung SH; Kim BY; Kim CH; Kang SK; Mok JO
J Diabetes Complications; 2017 Jan; 31(1):134-140. PubMed ID: 27839924
[TBL] [Abstract][Full Text] [Related]
5. Serum fibroblast growth factor 21 concentrations in type 2 diabetic retinopathy patients.
Esteghamati A; Momeni A; Abdollahi A; Khandan A; Afarideh M; Noshad S; Nakhjavani M
Ann Endocrinol (Paris); 2016 Oct; 77(5):586-592. PubMed ID: 27106505
[TBL] [Abstract][Full Text] [Related]
6. Association between serum fibroblast growth factor 21 level and sight-threatening diabetic retinopathy in Chinese patients with type 2 diabetes.
Jin S; Xia N; Han L
BMJ Open Diabetes Res Care; 2021 Mar; 9(1):. PubMed ID: 33789910
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and clinical profile of metabolic syndrome among type 1 diabetes mellitus patients in southern India.
Billow A; Anjana RM; Ngai M; Amutha A; Pradeepa R; Jebarani S; Unnikrishnan R; Michael E; Mohan V
J Diabetes Complications; 2015 Jul; 29(5):659-64. PubMed ID: 25899474
[TBL] [Abstract][Full Text] [Related]
8. Serum fibroblast growth factor 21 levels are correlated with the severity of diabetic retinopathy.
Lin Y; Xiao YC; Zhu H; Xu QY; Qi L; Wang YB; Li XJ; Zheng ML; Zhong RS; Zhang Y; Xu XD; Wu BL; Xu ZM; Lu XH
J Diabetes Res; 2014; 2014():929756. PubMed ID: 24895642
[TBL] [Abstract][Full Text] [Related]
9. Basal and postprandial change in serum fibroblast growth factor-21 concentration in type 1 diabetic mellitus and in healthy controls.
Zibar K; Blaslov K; Bulum T; Ćuća JK; Smirčić-Duvnjak L
Endocrine; 2015 Apr; 48(3):848-55. PubMed ID: 25194937
[TBL] [Abstract][Full Text] [Related]
10. Implications of the Diabetes Control and Complications Trial. American Diabetes Association.
Diabetes; 1993 Nov; 42(11):1555-8. PubMed ID: 8405694
[No Abstract] [Full Text] [Related]
11. Circulating fibroblast growth factor 21 levels predict progressive kidney disease in subjects with type 2 diabetes and normoalbuminuria.
Lee CH; Hui EY; Woo YC; Yeung CY; Chow WS; Yuen MM; Fong CH; Xu A; Lam KS
J Clin Endocrinol Metab; 2015 Apr; 100(4):1368-75. PubMed ID: 25625802
[TBL] [Abstract][Full Text] [Related]
12. Using insulin U 100 conversion to estimate the prevalence and problems of insulin-treated diabetic patients in the Republic of Seychelles.
Sullivan FM; Rosalie D; Sivakumar U
Diabetologia; 1990 Mar; 33(3):184-5. PubMed ID: 2184070
[No Abstract] [Full Text] [Related]
13. Circulating levels of fibroblast growth factor 21 in early-stage diabetic kidney disease.
Esteghamati A; Khandan A; Momeni A; Behdadnia A; Ghajar A; Nikdad MS; Noshad S; Nakhjavani M; Afarideh M
Ir J Med Sci; 2017 Aug; 186(3):785-794. PubMed ID: 28181108
[TBL] [Abstract][Full Text] [Related]
14. Distinct association of serum FGF21 or adiponectin levels with clinical parameters in patients with type 2 diabetes.
Eto K; Tumenbayar B; Nagashima S; Tazoe F; Miyamoto M; Takahashi M; Ando A; Okada K; Yagyu H; Ishibashi S
Diabetes Res Clin Pract; 2010 Jul; 89(1):52-7. PubMed ID: 20452080
[TBL] [Abstract][Full Text] [Related]
15. Serum concentrations of fibroblast growth factors 19 and 21 in women with gestational diabetes mellitus: association with insulin resistance, adiponectin, and polycystic ovary syndrome history.
Wang D; Zhu W; Li J; An C; Wang Z
PLoS One; 2013; 8(11):e81190. PubMed ID: 24260557
[TBL] [Abstract][Full Text] [Related]
16. Serum fibroblast growth factor 21 levels is associated with lower extremity atherosclerotic disease in Chinese female diabetic patients.
Zhang X; Hu Y; Zeng H; Li L; Zhao J; Zhao J; Liu F; Bao Y; Jia W
Cardiovasc Diabetol; 2015 Mar; 14():32. PubMed ID: 25850006
[TBL] [Abstract][Full Text] [Related]
17. The diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: the "gift" that keeps on giving!
Cefalu WT; Ratner RE
Diabetes Care; 2014; 37(1):5-7. PubMed ID: 24356590
[No Abstract] [Full Text] [Related]
18. The serum fibroblast growth factor 21 is correlated with retinopathy in patients with type 2 diabetes mellitus.
Heidari Z; Hasanpour M
Diabetes Metab Syndr; 2021; 15(6):102296. PubMed ID: 34592531
[TBL] [Abstract][Full Text] [Related]
19. SERUM LEVELS OF FIBROBLAST GROWTH FACTOR 21 IN TYPE 2 DIABETIC PATIENTS.
Panahi Y; Bonakdaran S; Yaghoubi MA; Keramati MR; Haratian M; Sahebkar A
Acta Endocrinol (Buchar); 2016; 12(3):257-261. PubMed ID: 31149098
[TBL] [Abstract][Full Text] [Related]
20. Circulating Diabetic Candidate Neurotrophic Factors, Brain-Derived Neurotrophic Factor and Fibroblast Growth Factor 21, in Sleeve Gastrectomy.
Yen HH; Hsieh ST; Chen CL; Yang WS; Lee PC; Lin MT; Chen CN; Yang PJ
Sci Rep; 2020 Mar; 10(1):5341. PubMed ID: 32210348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
